Publication Cover
Neurological Research
A Journal of Progress in Neurosurgery, Neurology and Neurosciences
Volume 43, 2021 - Issue 5
317
Views
9
CrossRef citations to date
0
Altmetric
Original Research Paper

Rifampicin ameliorates lipopolysaccharide-induced cognitive and motor impairments via inhibition of the TLR4/MyD88/NF-κB signaling pathway in mice

, , , , , & show all
Pages 358-371 | Received 06 Jul 2020, Accepted 13 Dec 2020, Published online: 21 Mar 2021

References

  • Finsen B, Owens T. Innate immune responses in central nervous system inflammation. FEBS Lett. 2011;585(23):3806–3812.
  • Kettenmann H, Hanisch UK, Noda M, et al. Physiology of microglia. Physiol Rev. 2011;91(2):461–553.
  • Elmore MR, Lee RJ, West BL, et al. Characterizing newly repopulated microglia in the adult mouse: impacts on animal behavior, cell morphology, and neuroinflammation. PLoS One. 2015;10(4):e0122912.
  • Frank-Cannon TC, Alto LT, McAlpine FE, et al. Does neuroinflammation fan the flame in neurodegenerative diseases. Mol Neurodegener. 2009;4:47.
  • Noh H, Jeon J, Seo H. Systemic injection of LPS induces region-specific neuroinflammation and mitochondrial dysfunction in normal mouse brain. Neurochem Int. 2014;69:35–40.
  • Badshah H, Ali T, Kim MO. Osmotin attenuates LPS-induced neuroinflammation and memory impairments via the TLR4/NFκB signaling pathway. Sci Rep. 2016;6:24493.
  • Rahimifard M, Maqbool F, Moeini-Nodeh S, et al. Targeting the TLR4 signaling pathway by polyphenols: A novel therapeutic strategy for neuroinflammation. Ageing Res Rev. 2017;36:11–19.
  • Malgorzata-Miller G, Heinbockel L, Brandenburg K, et al. Bartonella quintana lipopolysaccharide (LPS): structure and characteristics of a potent TLR4 antagonist for in-vitro and in-vivo applications. Sci Rep. 2016;6:34221.
  • Bossù P, Cutuli D, Palladino I, et al. A single intraperitoneal injection of endotoxin in rats induces long-lasting modifications in behavior and brain protein levels of TNF-α and IL-18. J Neuroinflammation. 2012;9:101.
  • Zhang Z, Hou L, Song JL, et al. Pro-inflammatory cytokine-mediated ferroportin down-regulation contributes to the nigral iron accumulation in lipopolysaccharide-induced Parkinsonian models. Neuroscience. 2014;257:20–30.
  • Guerreiro RJ, Santana I, Brás JM, et al. Peripheral inflammatory cytokines as biomarkers in Alzheimer’s disease and mild cognitive impairment. Neurodegener Dis. 2007;4(6):406–412.
  • Shin JH, Lee YA, Lee JK, et al. Concurrent blockade of free radical and microsomal prostaglandin E synthase-1-mediated PGE2 production improves safety and efficacy in a mouse model of amyotrophic lateral sclerosis. J Neurochem. 2012;122(5):952–961.
  • Yulug B, Kilic U, Kilic E, et al. Rifampicin attenuates brain damage in focal ischemia. Brain Res. 2004;996(1):76–80.
  • Marija M. Rifampicin: an immunosuppressant. Lancet. 1971;2(7730):930–931.
  • Bellahsène A, Forsgren A. Effect of rifampin on the immune response in mice. Infect Immun. 1980;27(1):15–20.
  • Nau R, Wellmer A, Soto A, et al. Rifampin reduces early mortality in experimental Streptococcus pneumoniae meningitis. J Infect Dis. 1999;179(6):1557–1560.
  • Tsiskarishvili NV, Tsiskarishvili NI. [The anti-tubercular drugs in the treatment of psoriasis]. Georgian Med News. 2009;174:25–28.
  • Namazi H. Practice pearl: a novel use of rifampicin for treatment of carpal tunnel syndrome. J Pain. 2008;9(4):380–381.
  • Ma K, Chen X, Chen JC, et al. Rifampicin attenuates experimental autoimmune encephalomyelitis by inhibiting pathogenic Th17 cells responses. J Neurochem. 2016;139(6):1151–1162.
  • Ali AE, Mahdy HM, Elsherbiny DM, et al. Rifampicin ameliorates lithium-pilocarpine-induced seizures, consequent hippocampal damage and memory deficit in rats: impact on oxidative, inflammatory and apoptotic machineries. Biochem Pharmacol. 2018;156:431–443.
  • Hu YD, Pang W, He CC, et al. The cognitive impairment induced by zinc deficiency in rats aged 0∼2 months related to BDNF DNA methylation changes in the hippocampus. Nutr Neurosci. 2017;20(9):519–525.
  • Micale V, Cristino L, Tamburella A, et al. Enhanced cognitive performance of dopamine D3 receptor “knock-out” mice in the step-through passive-avoidance test: assessing the role of the endocannabinoid/endovanilloid systems. Pharmacol Res. 2010;61(6):531–536.
  • Matsuura K, Kabuto H, Makino H, et al. Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion. J Neurosci Methods. 1997;73(1):45–48.
  • Hernández-Romero MC, Delgado-Cortés MJ, Sarmiento M, et al. Peripheral inflammation increases the deleterious effect of CNS inflammation on the nigrostriatal dopaminergic system. Neurotoxicology. 2012;33(3):347–360.
  • Aktan F. iNOS-mediated nitric oxide production and its regulation. Life Sci. 2004;75(6):639–653.
  • Aïd S, Bosetti F. Targeting cyclooxygenases-1 and −2 in neuroinflammation: therapeutic implications. Biochimie. 2011;93(1):46–51.
  • Laird MH, Rhee SH, Perkins DJ, et al. TLR4/MyD88/PI3K interactions regulate TLR4 signaling. J Leukoc Biol. 2009;85(6):966–977.
  • Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649–683.
  • Atreya I, Atreya R, Neurath MF. NF-kappaB in inflammatory bowel disease. J Intern Med. 2008;263(6):591–596.
  • Chui DH, Tabira T, Izumi S, et al. Decreased beta-amyloid and increased abnormal Tau deposition in the brain of aged patients with leprosy. Am J Pathol. 1994;145(4):771–775.
  • Qosa H, Abuznait AH, Hill RA, et al. Enhanced brain amyloid-β clearance by rifampicin and caffeine as a possible protective mechanism against Alzheimer’s disease. J Alzheimers Dis. 2012;31(1):151–165.
  • Ubhi K, Rockenstein E, Mante M, et al. Rifampicin reduces alpha-synuclein in a transgenic mouse model of multiple system atrophy. Neuroreport. 2008;19(13):1271–1276.
  • Kilic U, Kilic E, Lingor P, et al. Rifampicin inhibits neurodegeneration in the optic nerve transection model in vivo and after 1-methyl-4-phenylpyridinium intoxication in vitro. Acta Neuropathol. 2004;108(1):65–68.
  • Bi W, Zhu L, Jing X, et al. Parkinson’s disease. Neurol Sci. 2013;34(2):137–141.
  • Allison DJ, Ditor DS. The common inflammatory etiology of depression and cognitive impairment: a therapeutic target. J Neuroinflammation. 2014;11:151.
  • Kaur P, Sodhi RK. Memory recuperative potential of rifampicin in aluminum chloride-induced dementia: role of pregnane X receptors. Neuroscience. 2015;288:24–36.
  • Zhao J, Bi W, Xiao S, et al. Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice. Sci Rep. 2019;9(1):5790.
  • Richwine AF, Godbout JP, Berg BM, et al. Improved psychomotor performance in aged mice fed diet high in antioxidants is associated with reduced ex vivo brain interleukin-6 production. Brain Behav Immun. 2005;19(6):512–520.
  • Bettcher BM, Kramer JH. Inflammation and clinical presentation in neurodegenerative disease: a volatile relationship. Neurocase. 2013;19(2):182–200.
  • Zhao WX, Zhang JH, Cao JB, et al. Acetaminophen attenuates lipopolysaccharide-induced cognitive impairment through antioxidant activity. J Neuroinflammation. 2017;14(1):17.
  • Lana D, Ugolini F, Nosi D, et al. Alterations in the Interplay between neurons, astrocytes and microglia in the rat dentate gyrus in experimental models of neurodegeneration. Front Aging Neurosci. 2017;9:296.
  • Fukushima S, Furube E, Itoh M, et al. Robust increase of microglia proliferation in the fornix of hippocampal axonal pathway after a single LPS stimulation. J Neuroimmunol. 2015;285:31–40.
  • Herrera AJ, Tomás-Camardiel M, Venero JL, et al. Inflammatory process as a determinant factor for the degeneration of substantia nigra dopaminergic neurons. J Neural Transm (Vienna). 2005;112(1):111–119.
  • Kloss CU, Bohatschek M, Kreutzberg GW, et al. Effect of lipopolysaccharide on the morphology and integrin immunoreactivity of ramified microglia in the mouse brain and in cell culture. Exp Neurol. 2001;168(1):32–46.
  • Koedel U, Merbt UM, Schmidt C, et al. Acute brain injury triggers MyD88-dependent, TLR2/4-independent inflammatory responses. Am J Pathol. 2007;171(1):200–213.
  • Tamassia N, Le Moigne V, Calzetti F, et al. The MyD88-independent pathway is not mobilized in human neutrophils stimulated via TLR4. J Immunol. 2007;178(11):7344–7356.
  • Takeda K, Akira S. TLR signaling pathways. Semin Immunol. 2004;16(1):3–9.
  • Wang X, Grace PM, Pham MN, et al. Rifampin inhibits Toll-like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic pain. Faseb J. 2013;27(7):2713–2722.
  • Simon PS, Sharman SK, Lu C, et al. The NF-κB p65 and p50 homodimer cooperate with IRF8 to activate iNOS transcription. BMC Cancer. 2015;15:770.
  • Vallabhapurapu S, Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol. 2009;27:693–733.
  • Zhang W, Wei Q. Calcineurin stimulates the expression of inflammatory factors in RAW 264.7 cells by interacting with proteasome subunit alpha type 6. Biochem Biophys Res Commun. 2011;407(4):668–673.
  • Bi W, Jing X, Zhu L, et al. Inhibition of 26S protease regulatory subunit 7 (MSS1) suppresses neuroinflammation. PLoS One. 2012;7(5):e36142.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.